title: Vaccination against persistent viral infection exacerbates CD4+ T-cell-mediated immunopathological disease.
abstract: Lymphocytic choriomeningitis virus (LCMV) infection of normal mice results in a fatal immunopathologic meningitis mediated by CD8+ cytotoxic T lymphocytes (CTL). We have previously shown that female beta2-microglobulin-deficient (beta2m-/-) mice, which are also deficient in CD8+ T cells, are susceptible to LCMV-induced immune-mediated meningitis, characterized by significant weight loss and mortality. This LCMV disease in beta2m-/- mice is mediated by CD4+ T lymphocytes. Our previous studies have also demonstrated that male beta2m-/- mice are less susceptible than female beta2m-/- mice to LCMV-induced, immune-mediated mortality and weight loss. In this report, we show that vaccination of male beta2m-/- mice enhances immunopathology following intracranial infection with LCMV. We observed increased production of gamma interferon (IFN-gamma), an increase in CD4+ CTL precursor frequency, and an increased frequency of IFN-gamma-producing cells from spleen cells of vaccinated male beta2m-/- mice. Vaccinated male beta2m-/- mice also had significantly increased inflammation in the cerebrospinal fluid (CSF), characterized by a large CD4+ T-cell infiltrate. CSF cells from vaccinated mice showed increased production of IFN-gamma on day 7 postchallenge. Neither vaccinated nor control beta2m-/- mice were able to clear virus, and the two groups had similarly high levels of virus early after infection. These results suggest that the magnitude of the early immune response is more important than the level of virus in the brain in determining the outcome of immunopathology in beta2m-/- mice. We show here that vaccination can increase CD4+ T-cell-dependent immunopathology to a persistent viral infection.
authors.affiliation: Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, 53706, USA.
authors.forename: D
authors.initials: D
authors.lastname: Hildeman
authors.forename: D
authors.initials: D
authors.lastname: Yañez
authors.forename: K
authors.initials: K
authors.lastname: Pederson
authors.forename: T
authors.initials: T
authors.lastname: Havighurst
authors.forename: D
authors.initials: D
authors.lastname: Muller
mesh_terms: D000818:Animals; D001921:Brain / Q000821:virology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D002460:Cell Line; D006224:Cricetinae; D004195:Disease Models, Animal; D017353:Gene Deletion; D006023:Glycoproteins / Q000276:immunology; D007371:Interferon-gamma / Q000096:biosynthesis / Q000134:cerebrospinal fluid; D008216:Lymphocytic Choriomeningitis / Q000276:immunology* / Q000517:prevention & control / Q000821:virology; D008297:Male; D051379:Mice; D013154:Spleen / Q000821:virology; D014611:Vaccination; D014616:Vaccinia virus / Q000276:immunology; D014764:Viral Proteins / Q000276:immunology; D017735:Virus Latency; D015431:Weight Loss; D001613:beta 2-Microglobulin / Q000235:genetics / Q000276:immunology*
chemical_list: D006023:Glycoproteins; D014764:Viral Proteins; D001613:beta 2-Microglobulin; D007371:Interferon-gamma